more_reports

H.C. Wainwright & Co. Shares Buy Rating on Biotech Co.

Research Report
  ()
H.C. Wainwright & Co. analysts gave Unicycive Therapeutics Inc. (UNCY:NASDAQ) a Buy rating after the company announced the successful completion of the Phase 1 study for UNI-494 in healthy volunteers.
Tags: Biotechnology / Pharmaceuticals

Drill Bit Hits Thickest Intercept So Far at Lithium Asset

Research Report
  ()
Though these results became available post feasibility study, they still could be incorporated into the mine plan, noted a BMO Capital Markets report.
Tags: Cobalt / Lithium / Manganese

Mining Co. Reports High-Grade Copper and Silver Intercepts

Research Report
  ()
Trigon Metals Inc. (TM:TSX; PNTZF:OTCQB; TZU2:FRA) recently reported high-grade copper and silver intercepts from recent underground drilling near Shaft 1 at the Kombat mine in Namibia, according to an Atrium Research note.
Tags: Critical MetalsBase MetalsSilver

Mass. Biotech Receives FDA Approval

Research Report
  ()
Biofrontera Inc. (BFRI:NASDAQ) receieved FDA's approval of the company's supplemental Biologics License Application (sBLA) to expand the use of Ameluz for treating larger surface areas of actinic keratosis (AK) on the face and scalp, according to a Roth MKM research note.
Tags: Biotechnology / Pharmaceuticals

CT Biotech Ready for Clinical Milestones

Research Report
  ()
Trevi Therapeutics Inc. (TRVI:NASDAQ) has made progress in its clinical trials for Haduvio, particularly in treating chronic cough in idiopathic pulmonary fibrosis (IPF) patients and refractory chronic cough (RCC), according to an EF Hutton research note.
Tags: Biotechnology / Pharmaceuticals

Biotech Completes Last Patient Visit in Phase2b Osteosarcoma Trial

Research Report
  ()
Following OS Therapies Inc.'s (OSTX:NYSEAMERICAN) announcement that the last patient enrolled in their Phase 2b trial for OST-HER2 in recurred, resected Osteosarcoma (OS) has completed their final radiographical evaluation, the company received a Buy rating and high target price from EF Hutton.
Tags: Biotechnology / Pharmaceuticals

Co. Focused on Advancing Gold Project in Cote d'Ivoire

Research Report
  ()
The priority in this regard is obtaining additional funding to cover development costs, noted a National Bank of Canada report.
Tags: Gold

New Jersey Biotech Reports Positive Survival Data

Research Report
  ()
H.C. Wainwright & Co. analysts Dr. Joseph Pantginis gave PDS Biotechnology Corp. (PDSB:NASDAQ) a Buy rating and large target price.
Tags: Biotechnology / Pharmaceuticals

Gold Co. On Verge of Construction Gains Research Coverage

Research Report
  ()
This firm, advancing its shovel-ready gold project in Cote d'Ivoire, is rated Outperform by BMO Capital Markets, according to its initiation report.
Tags: Gold

Gold Co. Raises $180M, Receives Final Permits

Research Report
  ()
Exploration at this project in Cote d'Ivoire continues and a construction decision is expected in H2/24, noted a Beacon Securities report.
Tags: Gold

Royalty Corp. Gains Coverage and a Buy Rating

Research Report
  ()
Sailfish Royalty Corp. (FISH:TSX.V; OTC:SROYF) recently gained coverage from Atrium Research.
Tags: Gold

California Biotech's Target Price 200% Higher Than Current

Research Report
  ()
F Hutton analyst Jason Kolbert gave Anixa Biosciences Inc. (ANIX: NASDAQ) a high target price after it had announced it would be amending the protocol for its ongoing CAR-T therapy clinical trial for ovarian cancer, allowing for a second dose in certain patients.
Tags: Biotechnology / Pharmaceuticals

Exploration Co. Advances Kone Gold Project

Research Report
  ()
Ventum Capital recently iniated coverage on Montage Gold Corp. (MAU:TSX.V), with a Buy rating. Read to see what the analysts see as catalysts for this exploration and development company.
Tags: Gold

Uranium Co. Acquires Rio Tinto's Wyoming Assets

Research Report
  ()
Roth MKM raised its target price on Uranium Energy Corp. (UEC:NYSE AMERICAN) after its agreement to acquire Rio Tinto Plc.'s (RIO:NYSE; RIO:ASX; RIO:LSE; RTPPF:OTCPK) Wyoming uranium assets for US$175 million in cash.
Tags: Uranium

Target Price Raised on Biotech Co.

Research Report
  ()
In an updated assessment of Zymeworks Inc.'s (ZYME:NYSE; ZYME:TSX) pipeline potential and upcoming catalysts, H.C. Wainwright & Co. analysts raised their target price on the company.
Tags: Biotechnology / Pharmaceuticals

Dining, Entertainment Brand Revises Guidance for 2025

Research Report
  ()
The company cites persisting macroeconomic tailwinds as the reason it updated its outlook for the year, noted an Oppenheimer report.
Tags: Special Situations

Expert Investing Ideas

"WEX should have drilling results very soon."

–Chen Lin, What Is Chen Buying? What Is Chen Selling?


"At current gold prices, stories like SEA become economic."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"WEX has the potential to deliver big gains in the near future."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"I am happily buying back some shares of MAG at lower prices."

–Chen Lin, What Is Chen Buying? What Is Chen Selling?


"SEA got more good news on the permitting front."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"BFG reported an excellent hit on its first drill hole at Majuba Hill."

–Ron Struthers, Struthers Resource Stock Report


"DV technically is on the cusp of a huge breakout."

–Jordan Roy-Byrne, The Daily Gold


"MAG is in position to advance swiftly again."

–Clive Maund, CliveMaund.com


"DV appears to be edging towards a breakout."

–Clive Maund, CliveMaund.com


"SYH commenced its 2,500m summer drill program at Moore."

–Marcus Giannini, Haywood Securities


"WEX will use the money raised to advance a PFS on Doby George."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"OMM began a 3,000m diamond drill program at Wingdam."

–Bill Newman, Research Capital Corporation


Company News

BPAI:CSE; BPAIF:OTCQB
10/9/2024 – BrandPilot AI Enters $500+ Bn Programmatic Advertising Market Through Partnership with Revvim

SEA:TSX; SA:NYSE.MKT
10/9/2024 – Promising Results from Drilling at Seabridge Gold's Iskut Project

PGE:TSX.V; PGEZF:OTCQB; J0G:FSE
10/9/2024 – Stillwater Critical Minerals Signs MOU With US Strategic Metals

SYH:TSX.V; SYHBF:OTCQX; SC1P:FSE
10/8/2024 – Skyharbour Partner Medaro Mining Announces Exploration Plan for the Yurchison Uranium Project Located in the Athabasca Basin, Saskatchewan

TSX-V: LTH;OTCQX: LTHCF;FSE: H3N
10/8/2024 – Lithium Ionic Drills Thickest Intercept to Date at Bandeira: 1.39% Li?O over 65m in Brazil's Lithium Valley, Minas Gerais

DRY:TSXV; DRYGF:OTCQB
10/8/2024 – Dryden Gold Reports Record High-Grade Gold at Elora Project, Gold Rock Camp of 30.72 g/t Gold over 5.70 Meters

GCC:CSE; GCCFF:OTC; A0RLEP:WKN;3TZ:FSE
10/8/2024 – Golden Cariboo Intersects 85.83 m (281.59 ft) of 0.55 g/t Gold, Including 17.06 m (55.97 ft) of 1.75 g/t Gold from Surface

WEX:TSX.V;WEXPF:OTC
10/7/2024 – Western Exploration Reports Positive Assay Results From 2024 Drilling Program at Gravel Creek

ATLX:NASDAQ
10/7/2024 – Atlas Lithium Advances Its Salinas Project

TAU:TSXV; THSGF:OTCQX; A3EP87:WKN
10/7/2024 – Thesis Gold Announces Completion of 2024 Field Program: On Track to Commence PFS and EIA in Early 2025

LGD:TSX; LGDTF:OTCQX
10/7/2024 – Liberty Gold Closes TV Tower Sale Transaction

CSE: BFG;OTC:BFGFF;FWB:YW5
10/7/2024 – Giant Mining Majuba Hill Core Hole MHB-31 Shipped for Analysis

IMCX:CSE; IMIMF:OTCQB; 3MX:FRA
10/7/2024 – Interra Enters Purchase Agreement for the Stars Copper Project

EMO:TSX.V; EMOTF:OTCQB; LLJA:FSE
10/4/2024 – Emerita Sponsors First Sustainable Mining Event in Huelva Province - SIM 'Sustainable International Mining' Summit

SYH:TSX.V; SYHBF:OTCQX; SC1P:FSE
10/3/2024 – Skyharbour Enters Into Agreement to Option South Dufferin and Bolt Uranium Projects Located in the Athabasca Basin, Saskatchewan

GCX:TSX.V; GCXXF:OTCQB
10/2/2024 – Granite Creek Copper Discovers New Zone in 2024 Drilling at Carmacks Copper-Gold-Silver Project in Yukon, Canada

Streetwise Reader Icon Streetwise Key Charts
Gold Silver Copper Zinc Oil Gas Natural Gas Battery Metals Coal Uranium Pharma Biotech & Life Sci

Get Our Streetwise Reports' Research Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

CA Pharma Co. Reports Positive Phase 3 Data for Schizophrenia Treatment

Research Report
  ()
Reviva Pharmaceuticals Holdings Inc. (RVPH: NASDAQ) recently reported positive Phase 3 data for its Schizophrenia treatment. The company also noted it intends to file an NDA in the first quarter of 2026, according to an EF Hutton Research note.
Tags: Biotechnology / Pharmaceuticals

Copper Co. Achieves Key Production Milestone

Research Report
  ()
Trigon Metals Inc. (TM:TSX; PNTZF:OTCQB; TZU2:FRA) recently announced a significant production milestone and strategic operational changes, according to an Atrium Research note.
Tags: Base MetalsCritical Metals

Software Co. Secures Second Major Studio Win

Research Report
  ()
Pixelworks Inc. (PXLW:NASDAQ) recently reported it had secured Universal Studios as its second major domestic licensee for its TrueCut motion grading platform, according to a Roth MKM research note.
Tags: Technology

High Grade Intercepts From All Holes at This Gold Project

Research Report
  ()
Endurance Gold Corp (EDG:TSX.V; ENDGF:OTCPink; 3EG:Frankfurt) recently reported assay results showing high-grade gold intersections from all six drill holes, according to an Atrium Research note.
Tags: Gold

California Energy Co. Announces Normal Course Issuer Bid

Research Report
  ()
Kolibri Global Energy Inc. (KEI:TSX; KGEI:NASDAQ) recently announced its intention to make a normal course issuer bid, which Roth MKM analysts view as positive.
Tags: Oil & Gas - Exploration & Production